Department of Urology, Nanjing First Hospital, Nanjing Medical University, No. 68 Changle Road, Nanjing, 210006, Jiangsu, People's Republic of China.
Stem Cell Res Ther. 2022 Jun 7;13(1):238. doi: 10.1186/s13287-022-02921-0.
Endothelial progenitor cells (EPCs), which are a type of stem cell, have been found to have strong angiogenic and tissue repair capabilities. Extracellular vesicles (EVs) contain many effective components, such as cellular proteins, microRNAs, messenger RNAs, and long noncoding RNAs, and can be secreted by different cell types. The functions of EVs depend mainly on their parent cells. Many researchers have conducted functional studies of EPC-derived EVs (EPC-EVs) and showed that they exhibit therapeutic effects on many diseases, such as cardiovascular disease, acute kidney injury, acute lung injury, and sepsis. In this review article, we comprehensively summarized the biogenesis and functions of EPCs and EVs and the potent role of EPC-EVs in the treatment of various diseases. Furthermore, the current problems and future prospects have been discussed, and further studies are needed to compare the therapeutic effects of EVs derived from various stem cells, which will contribute to the accelerated translation of these applications in a clinical setting.
内皮祖细胞(EPCs)是一种干细胞,已被发现具有强大的血管生成和组织修复能力。细胞外囊泡(EVs)包含许多有效的成分,如细胞蛋白、microRNAs、信使 RNAs 和长非编码 RNAs,并可以由不同的细胞类型分泌。EVs 的功能主要取决于其亲本细胞。许多研究人员对 EPC 衍生的 EVs(EPC-EVs)进行了功能研究,表明它们对许多疾病具有治疗作用,如心血管疾病、急性肾损伤、急性肺损伤和脓毒症。在这篇综述文章中,我们全面总结了 EPCs 和 EVs 的发生和功能,以及 EPC-EVs 在治疗各种疾病中的重要作用。此外,还讨论了当前存在的问题和未来的展望,需要进一步研究比较来自各种干细胞的 EVs 的治疗效果,这将有助于加速这些应用在临床环境中的转化。
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2025
Front Pharmacol. 2024-12-18
Front Cell Dev Biol. 2024-12-12
Heliyon. 2024-10-11
Stem Cell Res Ther. 2024-8-26
Front Cardiovasc Med. 2021-10-4